TGF-β and cancer

Cytokine and Growth Factor Reviews

Volumn 17, Issue 1-2, 2006, Pages 29-40

  Bierie, Brian ^a,d   Moses, Harold L ^a,b,c,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d NONE   (United States)

Author keywords

Cancer; Cross talk; Epithelium; Interactions; Smad; Stroma; TGF

Indexed keywords

ANTHRACENE; HYBRID PROTEIN; INTEGRIN; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; NERVE CELL ADHESION MOLECULE; RAS PROTEIN; RECEPTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SCATTER FACTOR; SMAD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR PROMOTER; TUMOR SUPPRESSOR PROTEIN;

ADENOCARCINOMA; ANGIOGENESIS; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CARCINOMA IN SITU; CELL DIFFERENTIATION; COLON CANCER; EPITHELIUM CELL; FIBROBLAST; GLIOMA; HUMAN; IN VIVO STUDY; INVASIVE CARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAMMARY GLAND; METASTASIS; MYOFIBROBLAST; NONHUMAN; PANCREAS CANCER; PHOSPHORYLATION; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; STROMA; TUMOR GROWTH;

EID: 30944432734     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2005.09.006     Document Type: Article

References (112)

1. N.A. Bhowmick, E.G. Neilson, and H.L. Moses Stromal fibroblasts in cancer initiation and progression Nature 432 7015 2004 332 337
2. M.P. de Caestecker, E. Piek, and A.B. Roberts Role of transforming growth factor-beta signaling in cancer J Natl Cancer Inst 92 17 2000 1388 1402
3. K.E. de Visser, and W.M. Kast Effects of TGF-beta on the immune system: implications for cancer immunotherapy Leukemia 13 8 1999 1188 1199
4. O. De Wever, and M. Mareel Role of tissue stroma in cancer cell invasion J Pathol 200 4 2003 429 447
5. R. Derynck, R.J. Akhurst, and A. Balmain TGF-beta signaling in tumor suppression and cancer progression Nat Genet 29 2 2001 117 129
6. R.B. Dickson Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene Proc Natl Acad Sci USA 84 3 1987 837 841
7. R. Derynck Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors Cancer Res 47 3 1987 707 712
8. R.F. Tucker Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor Science 226 4675 1984 705 707
9. H.L. Moses, R.F. Tucker, E.B. Leof, R.J. Coffey Jr., J. Halper, and G.D. Shipley Type beta transforming growth factor is a growth stimulator and a growth inhibitor Cancer Cells 3 1985 65 71
10. H.L. Moses Transforming growth factor production by chemically transformed cells Cancer Res 41 7 1981 2842 2848
11. A.B. Roberts New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues Proc Natl Acad Sci USA 78 9 1981 5339 5343
12. D.F. Pierce Jr. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1 Genes Dev 7 12A 1993 2308 2317
13. L.M. Wakefield, and M.B. Sporn Suppression of carcinogenesis: a role for TGF-beta and related molecules in prevention of cancer Immunol Ser 51 1990 217 243
14. N. Dumont, A.V. Bakin, and C.L. Arteaga Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells J Biol Chem 278 5 2003 3275 3285
15. N. Dumont, and C.L. Arteaga Transforming growth factor-beta and breast cancer: tumor promoting effects of transforming growth factor-beta Breast Cancer Res 2 2 2000 125 132
16. P.J. Miettinen TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors J Cell Biol 127 6 Pt 2 1994 2021 2036
17. J. Zavadil Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta Proc Natl Acad Sci USA 98 12 2001 6686 6691
18. L. Xie Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line Breast Cancer Res 5 6 2003 R187 R198
19. A.V. Bakin p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration J Cell Sci 115 Pt 15 2002 3193 3206
20. A.V. Bakin Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration J Biol Chem 275 47 2000 36803 36810
21. N.A. Bhowmick Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism Mol Biol Cell 12 1 2001 27 36
22. M. Oft, K.H. Heider, and H. Beug TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis Curr Biol 8 23 1998 1243 1252
23. M. Oft TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells Genes Dev 10 19 1996 2462 2477
24. K.A. Brown Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro Breast Cancer Res 6 3 2004 R215 R231
25. A.B. Roberts, and L.M. Wakefield The two faces of transforming growth factor beta in carcinogenesis Proc Natl Acad Sci USA 100 15 2003 8621 8623
26. B. Pasche Role of transforming growth factor beta in cancer J Cell Physiol 186 2 2001 153 168
27. E. Ziv Association between the T29→C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures JAMA 285 22 2001 2859 2863
28. H. Gobbi Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia J Natl Cancer Inst 91 24 1999 2096 2101
29. J.S. de Jong Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer I: an inventory in search of autocrine and paracrine loops J Pathol 184 1 1998 44 52
30. J.S. de Jong Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II. Correlations with proliferation and angiogenesis J Pathol 184 1 1998 53 57
31. J. Barlow Higher stromal expression of transforming growth factor-beta type II receptors is associated with poorer prognosis breast tumors Breast Cancer Res Treat 79 2 2003 149 159
32. H. Tsushima High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression Gastroenterology 110 2 1996 375 382
33. P. Wikstrom Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer Prostate 37 1 1998 19 29
34. W.M. Grady Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers Cancer Res 59 2 1999 320 324
35. R.J. Akhurst, and R. Derynck TGF-beta signaling in cancer - a double-edged sword Trends Cell Biol 11 11 2001 S44 S51
36. C.D. Lucke Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer Cancer Res 61 2 2001 482 485
37. W.M. Grady Genomic instability and colon cancer Cancer Metastasis Rev 23 1-2 2004 11 27
38. S. Markowitz Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability Science 268 5215 1995 1336 1338
39. S. Seitz Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines Genes Chromosomes Cancer 37 1 2003 29 35
40. S. Takenoshita Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers Oncol Rep 5 2 1998 367 371
41. M. Kretzschmar Transforming growth factor-beta and breast cancer: transforming growth factor-beta/SMAD signaling defects and cancer Breast Cancer Res 2 2 2000 107 115
42. R. Derynck, and Y.E. Zhang Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 425 6958 2003 577 584
43. D. MacGrogan Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas Oncogene 15 9 1997 1111 1114
44. K. Eppert MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma Cell 86 4 1996 543 552
45. Y. Takagi Somatic alterations of the SMAD-2 gene in human colorectal cancers Br J Cancer 78 9 1998 1152 1155
46. J. Massague How cells read TGF-beta signals Nat Rev Mol Cell Biol 1 3 2000 169 178
47. J. Massague, and Y.G. Chen Controlling TGF-beta signaling Genes Dev 14 6 2000 627 644
48. G.C. Blobe, W.P. Schiemann, and H.F. Lodish Role of transforming growth factor beta in human disease N Engl J Med 342 18 2000 1350 1358
49. S.A. Hahn DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 5247 1996 350 353
50. M. Schutte DPC4 gene in various tumor types Cancer Res 56 11 1996 2527 2530
51. S. Thiagalingam Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers Nat Genet 13 3 1996 343 346
52. G. Xu, C. Chakraborty, and P.K. Lala Reconstitution of Smad3 restores TGF-beta response of tissue inhibitor of metalloprotease-1 upregulation in human choriocarcinoma cells Biochem Biophys Res Commun 300 2 2003 383 390
53. S.U. Han Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer Oncogene 23 7 2004 1333 1341
54. F. Tian Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines Cancer Res 63 23 2003 8284 8292
55. D.F. Pierce Jr. Mammary tumor suppression by transforming growth factor beta 1 transgene expression Proc Natl Acad Sci USA 92 10 1995 4254 4258
56. P.M. Siegel Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis Proc Natl Acad Sci USA 100 14 2003 8430 8435
57. B. Tang Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency Nat Med 4 7 1998 802 807
58. S.J. Engle Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis Cancer Res 59 14 1999 3379 3386
59. A.E. Gorska Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation Am J Pathol 163 4 2003 1539 1549
60. C. Amendt Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development Oncogene 17 1 1998 25 34
61. E.P. Bottinger Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas EMBO J 16 10 1997 2621 2633
62. W. Li Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice Development 130 24 2003 6143 6153
63. K. Takaku Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes Cell 92 5 1998 645 656
64. K. Takaku No effects of Smad2 (madh2) null mutation on malignant progression of intestinal polyps in Apc(delta716) knockout mice Cancer Res 62 16 2002 4558 4561
65. M.M. Taketo, and K. Takaku Gastrointestinal tumorigenesis in Smad4 (Dpc4) mutant mice Hum Cell 13 3 2000 85 95
66. E.P. Bottinger Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]- anthracene Cancer Res 57 24 1997 5564 5570
67. E. Forrester Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis Cancer Res 65 6 2005 2296 2302
68. D.R. Welch, A. Fabra, and M. Nakajima Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential Proc Natl Acad Sci USA 87 19 1990 7678 7682
69. Y. Ueda Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility J Biol Chem 279 23 2004 24505 24513
70. D.C. Yang, R.L. Elliott, and J.F. Head Gene targets of antisense therapies in breast cancer Expert Opin Ther Targets 6 3 2002 375 385
71. R.S. Muraoka-Cook Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors Cancer Res 64 24 2004 9002 9011
72. R.S. Muraoka Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases J Clin Invest 109 12 2002 1551 1559
73. A. Bandyopadhyay A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells Cancer Res 59 19 1999 5041 5046
74. S.W. Hayward Malignant transformation in a non-tumorigenic human prostatic epithelial cell line Cancer Res 61 22 2001 8135 8142
75. A. Orimo Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 3 2005 335 348
76. M. Allinen Molecular characterization of the tumor microenvironment in breast cancer Cancer Cell 6 1 2004 17 32
77. M.H. Barcellos-Hoff, and S.A. Ravani Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells Cancer Res 60 5 2000 1254 1260
78. C. Kuperwasser Reconstruction of functionally normal and malignant human breast tissues in mice Proc Natl Acad Sci USA 101 14 2004 4966 4971
79. G.R. Cunha, B.A. Reese, and M. Sekkingstad Induction of nuclear androgen-binding sites in epithelium of the embryonic urinary bladder by mesenchyme of the urogenital sinus of embryonic mice Endocrinology 107 6 1980 1767 1770
80. N. Cheng Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks Oncogene 24 32 2005 5053 5068
81. A. Chytil Conditional inactivation of the TGF-beta type II receptor using Cre:Lox Genesis 32 2 2002 73 75
82. N.A. Bhowmick TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 303 5659 2004 848 851
83. M.J. Calonge, and J. Massague Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells J Biol Chem 274 47 1999 33637 33643
84. A.E. Postlethwaite Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta J Exp Med 165 1 1987 251 256
85. O. De Wever Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac FASEB J 18 9 2004 1016 1018
86. O. De Wever Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding J Cell Sci 117 Pt 20 2004 4691 4703
87. M.P. Lewis Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells Br J Cancer 90 4 2004 822 832
88. I.F. San Francisco Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts Int J Cancer 112 2 2004 213 218
89. M.J. Gerdes Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1 Prostate 58 3 2004 299 307
90. K.A. Lygoe AlphaV integrins play an important role in myofibroblast differentiation Wound Repair Regen 12 4 2004 461 470
91. A.K. Scaffidi Alpha(v)beta(3) Integrin interacts with the transforming growth factor beta (TGFbeta) type II receptor to potentiate the proliferative effects of TGFbeta1 in living human lung fibroblasts J Biol Chem 279 36 2004 37726 37733
92. R.C. Chambers Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching Am J Pathol 162 2 2003 533 546
93. K. Matsumoto Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids J Biol Chem 267 35 1992 24917 24920
94. C.T. Guy Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease Proc Natl Acad Sci USA 89 22 1992 10578 10582
95. Y. Matsui Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice Cell 61 6 1990 1147 1155
96. M.I. Gallego, B. Bierie, and L. Hennighausen Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways Oncogene 22 52 2003 8498 8508
97. J.R. Howe Mutations in the SMAD4/DPC4 gene in juvenile polyposis Science 280 5366 1998 1086 1088
98. B.L. Loeys A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 Nat Genet 37 3 2005 275 281
99. K.L. Woodford-Richens SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway Proc Natl Acad Sci USA 98 17 2001 9719 9723
100. T. Mizuguchi Heterozygous TGFBR2 mutations in Marfan syndrome Nat Genet 36 8 2004 855 860
101. W. Friedl Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients Genes Chromosomes Cancer 25 4 1999 403 406
102. S.L. Lu HNPCC associated with germline mutation in the TGF-beta type II receptor gene Nat Genet 19 1 1998 17 18
103. M.C. Yakicier Smad2 and Smad4 gene mutations in hepatocellular carcinoma Oncogene 18 34 1999 4879 4883
104. C.J. Gallione A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4) Lancet 363 9412 2004 852 859
105. S. Tanaka A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma Br J Cancer 82 9 2000 1557 1560
106. R. Houlston Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases Hum Mol Genet 7 12 1998 1907 1912
107. A.P. Berger Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia Prostate 57 1 2003 57 65
108. T. Chen Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases Int J Cancer 93 5 2001 653 661
109. W. Friedl Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers Hum Genet 111 1 2002 108 111
110. T. Chen Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer Cancer Res 58 21 1998 4805 4810
111. R. Anbazhagan The S387Y mutations of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma Cancer Res 59 14 1999 3363 3364
112. S.K. Kim DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma Cancer Res 56 11 1996 2519 2521